Godfrey Dzhivhuho has dedicated his career to understanding HIV and other infectious diseases, inspired by the epidemic he witnessed growing up. Raised in Warrenton-Kimberly, South Africa, the oldest ...
Gilead Sciences' new shot is a drug named lenacapavir, which was tested in two studies and reportedly eliminated HIV infections in high-risk patients. People have to test negative for HIV before they ...
You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...
The Parkland Center for Clinical Innovation (PCCI) is using AI to tackle a persistent problem: HIV infections. PCCI's Vice President of Clinical and Social Health explains how it works. Editor’s Note: ...
The Food and Drug Administration approved a twice-yearly shot that prevented HIV infections in 99.9% of the people who received it in large clinical trials. The drug, developed by Gilead Sciences and ...
A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.
CHANCES ARE, YOU'RE under the assumption that HIV is no longer a serious concern. Treatments work. Prevention works. When people living with HIV are treated consistently and achieve viral suppression, ...
What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best option for them?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results